AESARA

Join Us at OPEX Week: Business Transformation World Summit 2025! We’re thrilled to share that Martin Rost will be participating in a panel discussion focused on Enhancing Cross-functional Efficiency in Pharma R&D and Commercialization! Martin will join our ARYSANA partner Gavin Outteridge and biopharma colleagues to discuss: 🔹 Addressing the productivity challenges that persist in pharma and biotech 🔹 Breaking down functional silos to meet rigorous evidence-generation demands 🔹 Creating a culture of continuous improvement aligned with business objectives 🔹 Developing integrated change plans to sustain transformational initiatives 🗓️ When: Monday January 27th, 2025 at 12 pm We look forward to seeing you in Miami! #PharmaInnovation #Biotech #R&D #OPEXWeek2025 #ChangeLeadership #ProcessOptimization #Miami #MarketAccess

Are you ready for the IRA in 2025? As we step into the new year, the Centers for Medicare & Medicaid Services (CMS) have provided critical updates, including their explanation of Maximum Fair Prices (MFPs) for the first 10 drugs selected for repricing, effective January 1, 2026. Amid ongoing uncertainties surrounding the Inflation Reduction Act (IRA) and its potential implications, our team at AESARA is actively monitoring these developments. We are committed to supporting your organization in navigating these changes and staying aligned with your preparations. Let’s work together to ensure you're well-prepared for the road ahead. #ValueandAccess #MarketAccess #HEOR #HealthcareInsights #DrugPricing #PharmaUpdates #IRA #InflationReductionAct #CMS #Biopharma #Biopharmaceutial #EvidenceGeneration #AESARA

Our team is excited to announce that we will be exhibiting at the Arab Health 2025 conference in Dubai, UAE on January 27-30! We are looking forward to gaining insights, exploring innovations, and contributing to discussions that shape the future of healthcare. Thank you to the Economic Development Partnership of North Carolina (EDPNC) for leading our North Carolina delegation at the Arab Health Exhibition #ArabHealth2025 #HealthcareInnovation #Dubai #Networking #GlobalHealth #HEOR #MarketAccess

This year has been nothing short of transformational for our team. We want to thank our incredible employees, clients, and partners for making 2024 such a successful and memorable journey. Your trust and collaboration have made all the difference. We’ve accomplished so much together, and we couldn’t have done it without you! As we step into 2025, we draw strength from our core values of being Bold, Trusted, and Transformative. Wishing you a joyous holiday season and a Happy New Year! 🎉 #HappyNewYear

Super late to announce the amazing news, but I’d like to share that I have accepted a Post-Doctoral Fellowship with AESARA in collaboration with UNC Eshelman School of Pharmacy as a Health Outcomes & Market Access Fellow! I am so blessed and excited for this new chapter of my life, and I could not have done it without the support of my mentors and friends! I have met so many kind and amazing people along the journey to getting this fellowship, and I would like to express my sincere gratitude for believing in me. I know with the guidance of the outstanding AESARA-UNC team, I will be successful in my future career! This was the best Christmas gift I could have received! After graduation, my new chapter begins in North Carolina. Looking forward to all the new experiences and challenges as I work towards my goals.

 🎉 WELCOME Andy Fuller 🎉 🎄 We’re thrilled to spread some holiday cheer and announce the addition of Andy Fuller to our strategic partnerships team! Andy brings over 27 years of experience within the pharmaceutical industry. During his career, Andy has successfully held multiple Commercial Leadership roles across Sales, Marketing, and Market Access. He was responsible for providing the strategic direction and execution of critical go-to-market strategies and payer engagement strategies across multiple channels within highly competitive markets. Welcome, Andy! #AESARA #MarketAccess #Marketing  #ChangeBeforeChange #HEOR #HealthEconomics #Innovation #ValueandAccess #Biopharma

I am both excited and proud to announce that I have accepted a Post-Doctoral Fellowship with AESARA in collaboration with UNC Eshelman School of Pharmacy as a Health Outcomes & Market Access Fellow! Not only am I excited to return to my alma mater, but I am eager to collaborate with and learn from experienced pharmaceutical industry leaders and professors from the top pharmacy school in the nation to further my knowledge and experience within the Health Economics & Outcomes Research (HEOR) and Market Access field. I would like to thank my mentors for all of their guidance and insight during this process. I would also like to thank my family and friends for their constant support and prayers. Lastly, thank you to the AESARA-UNC team for believing in me and giving me this opportunity! I look forward to beginning this new chapter with AESARA following my graduation from Howard University College of Pharmacy in May 2025. God has truly blessed me with the perfect opportunity for me and I cannot wait to continue to improve patient access for all! #AESARA #UNCChapelHill #HEOR #HealthOutcomes #MarketAccess #GoHeels

🎉 WELCOME Martin Rost 🎉 We are pleased to bolster our market access capabilities with the addition of a new member to our Value Evidence Team, Martin Rost! Martin is a highly experienced Global Access Leader with over 20 years in the industry, having held key market access roles at Novartis and Pfizer. He brings a creative, results-driven mindset and a proven track record of leadership. His expertise spans local, regional, and global roles, where he has successfully implemented innovative market access solutions and led the development of highly effective cross-functional teams. Welcome, Martin! #AESARA #MarketAccess #Pricing #Value #ChangeBeforeChange #HEOR #HealthEconomics #Innovation #ValueandAccess #Biopharma

This year's ISPOR EU in Barcelona was an incredible experience, full of innovative and thought-provoking conversations about the future of healthcare. Here are some key themes that stood out to our team during the event: 💡 Impact of HEOR Case studies demonstrating the real-world value of HEOR in policy research, including real-world cases from the UK. A compelling call to action to better measure and communicate the impact of HEOR in pharma 📊 Economic Modeling Methodology Insights on the evolving "value flower" framework. Advances in cure models, paving the way for more robust evaluations. 🤖 AI Application for HTA The evolving role of AI in evidence synthesis and programming in R and Python, showing how technology continues to transform HTA 📋 RWD Usage in Europe Addressing challenges around the standardization of RWD and tackling privacy concerns to unlock its full potential. 🧬 Evolving Areas Progress in gene therapy and innovations in medical devices and diagnostics, emphasize the interdisciplinary nature of the HEOR field. These discussions underline the dynamic nature of HEOR and its critical role in advancing healthcare decision-making. A big thank you to all the speakers, organizers, and participants who made this event a success. Together, let’s continue to drive impact and innovation! #ISPOREU2024 #HEOR #HealthEconomics #Innovation #RealWorldEvidence #HTA Let us know what your favorite insights from ISPOR Europe 2024 were! 👇

Our team has been assessing the accuracy of AI-driven translations in health economics and outcomes research (HEOR) publications. With HEOR’s technical language and global audience, we’re exploring how well AI handles these complexities and where human expertise remains essential. We will be presenting a poster on the findings of this study at ISPOR Europe in Barcelona titled ‘Is Artificial Intelligence Ready to Tackle Language Barriers for Health Economics and Outcomes Research?’ Reach out to our lead authors Wei-Shi (Danny) Yeh, Claudia Roeder, Catherine Chamoux, Roberta Longo, FADI M. to discuss the results further! #ValueandAccess #HEOR #MarketAccess #ISPOR #ISPOREurope #ISPOREurope2024 #biopharma #Biopharmaceutical #AESARA #AI #AIinBiopharma